Navigation Links
Glaucoma Research Foundation to Hold Annual Fundraising Benefit
Date:1/28/2009

SAN FRANCISCO, Jan. 28 /PRNewswire/ -- The Glaucoma Research Foundation is holding its Annual Fundraising Benefit this evening in San Francisco. This annual event will take place at the Palace Hotel and serves as the showcase for recent advances in GRF-funded research.

The Benefit begins at 5 pm with a scientific overview of recent research advances presented by the four principal investigators of GRF's Catalyst for a Cure (CFC) consortium. A reception follows at 6 p.m. and dinner commences at 7 p.m.

Glaucoma is the leading cause of preventable blindness. With an aging population, millions worldwide risk blindness from glaucoma if nothing is done. "We believe that a cure is someday on the horizon, and our primary mission going into 2009 is to continue to provide the best treatment and education to those who suffer from this disease," says Thomas M. Brunner, GRF president and CEO.

Established by GRF in 2000, the CFC was first proposed as a partnership by the Steven and Michele Kirsch Foundation on the premise that the search for a cure should be a priority, and that the pace of discovery could be accelerated with important innovations: instead of the traditional academic approach of sole scientists working in isolation, the project would bring together investigators with complementary skills working together in a genuine, real-time collaboration.

Located in San Francisco and now celebrating its 31st year, GRF is the nation's most experienced foundation dedicated solely to glaucoma research and education. In addition to funding innovative research like the Catalyst For a Cure research consortium and its Shaffer Grants for Innovative Glaucoma Research, GRF also is the "go to" agency for education materials, including the definitive reference for newly diagnosed, Understanding and Living with Glaucoma, and specialized brochures to serve those at highest risk, including African-Americans, Latinos, and children. For more information about GRF, visit their website http://www.glaucoma.org, or call 800.826.6693.

About the Glaucoma Research Foundation

Glaucoma is the leading cause of preventable blindness. Founded in 1978 in San Francisco, the Glaucoma Research Foundation is the oldest national foundation dedicated to preventing vision loss from glaucoma by investing in innovative research, education and support with the ultimate goal of finding a cure.


Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Thomas M. Brunner
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72634


'/>"/>
SOURCE The Glaucoma Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Glaucoma surgery in the blink of an eye
3. Glaucoma surgery in the blink of an eye
4. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
5. Looking at Glaucoma as a Systemic Disease
6. Cost of glaucoma medications may impact treatment
7. January is National Glaucoma Awareness Month
8. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
9. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
10. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
11. Glaucoma May Boost Cardiovascular Death Risk in Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... GA (PRWEB) , ... February 17, 2017 , ... Like ... to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), ... been a key focus area for hospitals across the nation. While many providers are ...
(Date:2/16/2017)... York, New York (PRWEB) , ... February 17, ... ... work and determination. After what took over 10 years of research, development and ... technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... Ontario , Feb. 16, 2017  Aralez Pharmaceuticals ... global specialty pharmaceutical company, today announced that executive management ... Conference to be held February 22-23, 2017. Adrian ... of the Company at 1:35 p.m. local time on ... and audio archive for the event may be accessed ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
Breaking Medicine Technology: